Apollo Endosurgery, Inc. (NASDAQ:APEN) Files An 8-K Results of Operations and Financial Condition

Apollo Endosurgery, Inc. (NASDAQ:APEN) Files An 8-K Results of Operations and Financial Condition
Item 2.02Results of Operations and Financial Condition.

Story continues below

OnAugust1, 2017, the Company issued a press release reporting its financial results for the fiscal quarter endedJune30, 2017. A copy of the Company’s press release is attached hereto as Exhibit 99.1.

The press release attached hereto as Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that Section or Sections11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits

Exhibit No.

Description of Document

99.1

Press release, issued by Apollo Endosurgery, Inc., dated August 1, 2017.


Apollo Endosurgery, Inc. Exhibit
EX-99.1 2 a2017q2ex-991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1APOLLO ENDOSURGERY,…
To view the full exhibit click here

About Apollo Endosurgery, Inc. (NASDAQ:APEN)

Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company’s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company’s products include ORBERA, LAP-BAND and OverStitch. The Company’s product, ORBERA, is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract.

An ad to help with our costs